本页面由Tiger Trade Technology Pte. Ltd.提供服务

ARS PHARMACEUTICALS INC

4.05
-0.1300-3.11%
盘后:4.050.00000.00%16:28 EDT
成交量:154.68万
成交额:627.50万
市值:4.03亿
市盈率:-1.86
高:4.18
开:4.18
低:4.00
收:4.18
52周最高:13.15
52周最低:3.99
股本:9,944.73万
流通股本:4,803.45万
量比:1.17
换手率:3.22%
股息:- -
股息率:- -
每股收益(TTM):-2.1757
每股收益(LYR):-1.7400
净资产收益率:-210.35%
总资产收益率:-48.02%
市净率:32.19
市盈率(LYR):-2.33

数据加载中...

2026/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

重要事件披露

Form 8-K - Current report
2026/07/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]